110
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Serum levels of interleukin-33, soluble ST2 and IgE in patients with asthma: a case-control study

, M.Sc, , MD, , PhD & , PhD
Pages 48-57 | Received 14 Mar 2023, Accepted 01 Aug 2023, Published online: 17 Aug 2023

Reference

  • Hough KP, Curtiss ML, Blain TJ, Liu R-M, Trevor J, Deshane JS, Thannickal VJ. Airway remodeling in asthma. Front Med (Lausanne). 2020;7:191. doi:10.3389/fmed.2020.00191.
  • Krishna MT, Mahesh PA, Vedanthan PK, Mehta V, Moitra S, Christopher DJ. The burden of allergic diseases in the Indian subcontinent: barriers and challenges. Lancet Glob Health. 2020;8(4):e478–e9. doi:10.1016/S2214-109X(20)30061-9.
  • Zhu X, Cui J, Yi L, Qin J, Tulake W, Teng F, Tang W, Wei Y, Dong J. The role of T cells and macrophages in asthma pathogenesis: a new perspective on mutual crosstalk. Mediators Inflamm. 2020;2020:7835284. doi:10.1155/2020/7835284.
  • Bradding P. Mast cell regulation of airway smooth muscle function in asthma. Eur Respir J. 2007;29(5):827–830. doi:10.1183/09031936.00017707.
  • Gautier C, Charpin D. Environmental triggers and avoidance in the management of asthma. J Asthma Allergy. 2017;10:47–56. doi:10.2147/JAA.S121276.
  • Cayrol C. IL-33, an alarmin of the IL-1 family involved in allergic and nonallergic inflammation: focus on the mechanisms of regulation of its activity. Cells. 2021;11(1):107. doi:10.3390/cells11010107.
  • Saluja R, Khan M, Church MK, Maurer M. The role of IL-33 and mast cells in allergy and inflammation. Clin Transl Allergy. 2015;5:33. doi:10.1186/s13601-015-0076-5.
  • Borish L, Steinke JW. Interleukin-33 in asthma: how big of a role does it play? Curr Allergy Asthma Rep. 2011;11(1):7–11. doi:10.1007/s11882-010-0153-8.
  • Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118(11):3546–3556. doi:10.1172/JCI36130.
  • Gabryelska A, Kuna P, Antczak A, Białasiewicz P, Panek M. IL-33 mediated inflammation in chronic respiratory diseases-understanding the role of the member of IL-1 superfamily. Front Immunol. 2019;10:692. doi:10.3389/fimmu.2019.00692.
  • Momen T, Ahanchian H, Reisi M, Shamsdin SA, Shahsanai A, Keivanfar M. Comparison of interleukin-33 serum levels in asthmatic patients with a control group and relation with the severity of the disease. Int J Prev Med. 2017;8:65. doi:10.4103/ijpvm.IJPVM_179_16.
  • Gasiuniene E, Janulaityte I, Zemeckiene Z, Barkauskiene D, Sitkauskiene B. Elevated levels of interleukin-33 are associated with allergic and eosinophilic asthma. Scand J Immunol. 2019;89(5):e12724. doi:10.1111/sji.12724.
  • Mato N, Bando M, Yamasawa H, Hosono T, Mizushina Y, Sata M, et al. Role of IL-33 in bronchial asthma. Nihon Kokyuki Gakkai Zasshi. 2010;48(6):419–25.
  • Li R, Yang G, Yang R, Peng X, Li J. Interleukin-33 and receptor ST2 as indicators in patients with asthma: a meta-analysis. Int J Clin Exp Med. 2015;8(9):14935–14943.
  • Griesenauer B, Paczesny S. The ST2/IL-33 axis in immune cells during inflammatory diseases. Front Immunol. 2017;8:475. doi:10.3389/fimmu.2017.00475.
  • Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, Nickl S, Dome B, Tschachler E, Ankersmit HJ, et al. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res. 2010;87(4):769–777. doi:10.1093/cvr/cvq104.
  • Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282(36):26369–26380. doi:10.1074/jbc.M704916200.
  • Urban MH, Stojkovic S, Demyanets S, Hengstenberg C, Valipour A, Wojta J, et al. Soluble ST2 and all-cause mortality in patients with chronic obstructive pulmonary disease-a 10-year cohort study. J Clin Med. 2021;11(1):56. doi:10.3390/jcm11010056.
  • Watanabe M, Nakamoto K, Inui T, Sada M, Honda K, Tamura M, Ogawa Y, Yokoyama T, Saraya T, Kurai D, et al. Serum sST2 levels predict severe exacerbation of asthma. Respir Res. 2018;19(1):169. doi:10.1186/s12931-018-0872-2.
  • Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001;164(2):277–281. doi:10.1164/ajrccm.164.2.2008120.
  • Raeiszadeh Jahromi S, Mahesh PA, Jayaraj BS, Madhunapantula SRV, Holla AD, Vishweswaraiah S, Ramachandra NB. Serum levels of IL-10, IL-17F and IL-33 in patients with asthma: a case-control study. J Asthma. 2014;51(10):1004–1013. doi:10.3109/02770903.2014.938353.
  • Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, Martin JG, Hamid Q. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009;183(8):5094–5103. doi:10.4049/jimmunol.0802387.
  • Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, Chaudhuri R, Thomson NC, McKenzie ANJ, McInnes I, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. doi:10.1111/j.1398-9995.2012.02859.x.
  • Tworek D, Majewski S, Szewczyk K, Kiszałkiewicz J, Kurmanowska Z, Górski P, Brzeziańska-Lasota E, Kuna P, Antczak A. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD. Respir Res. 2018;19(1):108. doi:10.1186/s12931-018-0807-y.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.